Astrazeneca (AZN) Goodwill & Intangibles (2009 - 2026)

Astrazeneca has reported Goodwill & Intangibles for 18 years, with the latest figure at $58.9 billion in Q2 2026.

• On a quarterly basis, Goodwill & Intangibles changed 0.41% year-over-year to $58.9 billion in Q2 2026; TTM through Jun 2026 was $58.9 billion, a 0.41% change from a year earlier, with the FY2025 full-year figure at $59.1 billion, up 1.52% from the prior year.
• Goodwill & Intangibles was $58.9 billion for Q2 2026 at Astrazeneca, up from $58.1 billion in the prior quarter.
• The five-year high for Goodwill & Intangibles was $61.2 billion in Q1 2022, with the low at $57.6 billion in Q3 2023.
• Average Goodwill & Intangibles over 5 years is $59.1 billion, with a median of $59.1 billion recorded in 2022.
• The largest YoY upside for Goodwill & Intangibles was 90.67% in 2022 against a maximum downside of 7.62% in 2022.
• Over 5 years, Goodwill & Intangibles stood at $59.1 billion in 2022, then slipped by 1.67% to $58.1 billion in 2023, then increased by 0.11% to $58.2 billion in 2024, then increased by 1.52% to $59.1 billion in 2025, then fell by 0.31% to $58.9 billion in 2026.
• The last three Goodwill & Intangibles figures came in at $58.9 billion (Q2 2026), $58.1 billion (Q1 2026), and $59.1 billion (Q4 2025), per Business Quant data.